Skip to main content

‘Power List’ Names Moran Eye Center Doctors and Researchers as Most Influential Worldwide

Ike Ahmed, MD, FRCSC, is director of the Crandall Center.
Ike Ahmed, MD, FRCSC

The John A. Moran Eye Center is home to the world’s most influential physicians and researchers in the field of ophthalmology, according to the latest rankings published by The Ophthalmologist magazine. 

The magazine named Iqbal "Ike" K. Ahmed, MD, FRCSC, director of the Moran Eye Center’s Alan S. Crandall Center for Glaucoma Innovation, No. 1 on its annual Power List of the 100 most influential people in ophthalmology.

Ahmed is recognized as one of the world’s top surgeons for complex eye conditions and is renowned for his groundbreaking research in the surgical treatment of diseases, including glaucoma and surgical complications. Known as the father of micro-invasive glaucoma surgery (MIGS), Ahmed splits his time between his practices in Canada and at the Moran Eye Center. 

A panel of 15 judges ranks the first 20 members on the Power List in order of impact within the field; the rest appear alphabetically.

Also ranked among the 100 from the Moran Eye Center:

Randall J Olson, MD
Randall J Olson, MD
Gregory S. Hageman, PhD
Gregory S. Hageman, PhD
Nick Mamalis, MD
Nick Mamalis, MD
Liliana Werner, MD, PhD
Liliana Werner, MD, PhD
  • Liliana Werner, MD, PhD. Werner is recognized as a foremost authority on intraocular lens technology. She co-directs the Moran-based Intermountain Ocular Research Center, a non-profit that performs scientific research on artificial intraocular lenses used to replace the eye’s natural lens. Companies worldwide use Werner’s expertise to vet new products and investigate lens-related complications.
  • Nick Mamalis, MD. Mamalis is a renowned clinician-scientist who co-directs the Intermountain Ocular Research Center and directs Moran’s Ophthalmic Pathology Laboratory. Mamalis is a past president of the American Society of Cataract and Refractive Surgery and has helped hospitals around the country protect patients from a sight-threatening inflammatory syndrome known as TASS.

View The Power List 2024